Patent · US Expired

Use of chondroitin sulphate E (CS-E) for the treatment of diseases or conditions related to collagen fibril formation

US7956047B2 · kind B2 · utility

0Cited by

5References

18Claims

0Family size

Assignee

ANAMAR AB · SE

Inventors

Anders Aspberg · Lund, SE
Dick Heinegard · Lund, SE
Anna M. Johnson · Willoughby, US
Alexander Kvist · Lund, SE

Key dates

Filing date	Apr 26, 2005
Grant date	Jun 7, 2011
Priority date	—
Expiry date	Apr 26, 2025

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P19/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention comprises the use of chondroitin sulphate (CS-E) or an active fragment thereof for the treatment of diseases or conditions related to collagen fibril formation. Said compounds can be administrated either by oral, topical, injectable or by any other suitable route.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.